|
|
 |
|
Viewing report
|
|
|
|
Hormonal Contraception: Market Update - Surviving the Generic Threat
Datamonitor, March 2003, Pages: 35
Hormonal contraception is a mature and overcrowded market, dominated by oral products, where high-levels of contraceptive efficacy are the norm.
The market is worth over $4bn, the majority of which comes from the US, 2.5bn.
Achieving success in this arena will depend on product differentiation, a factor that will become increasingly important as generic drugs flood into the market.
Report Scope:
Analysis of the current position of the oral contraceptive market leader Ortho Tri-Cyclen and contributing factors to its success.
Strategies for survival post patent expiry including product reformulation, geographical expansion and additional / non-contraceptive indications.
Assessment of key competitors in the market and the potential of core proprietary products against growing generic pressure.
Report Highlights:
Ortho McNeil’s strategies to survive the patent expiry of Ortho Tri-Cyclen will not be successful in the short term, leading to a loss in revenues and value of its contraception franchise.
While oral contraceptives are expected to continue to dominate, product differentiation remains key in gaining a competitive edge in the market. Strategies are set to focus on reformulation and the pursuit of additional indications.
Already a fragmented and poorly differentiated market, the specter of genericization and generic substitution is a growing threat to major players, particularly as managed care organizations are poised to exploit low-cost equivalents.
Reasons to Purchase Report:
Learn what Ortho McNeil is / should be doing to keep lost revenue to a minimum as the patent on Ortho Tri-Cyclen approaches expiry
Assess how this key event in the oral contraceptive market will impact upon the other major players: Schering AG, Wyeth, Organon and Barr
Customers who bought this item also bought
Commercial Insight: Hormonal Contraceptives - Look Beyond Oral Contraception for a Competitive Edge
Strategic Perspectives 2001: Hormonal contraceptives
Stakeholder Opinions: Hormonal Contraceptives - New directions in a competitive market
The Global Market For Hormonal Contraceptives and Infertility Drugs, 2005-2012
Women's Health Series: How Have New Oral Contraceptives Changed the Market?
Hormonal Contraceptives Market Forecast
Oral Contraceptives & Condom Market: An Analysis
Contraception Market Report 2009
Contraception Market Report 2007
Contraceptives - Global Strategic Business Report
Generic Benchmarking: Brand Erosion at Patent Expiry
Generic Series: Benchmarking Patent Expiries - Key Factors Affecting Brand Erosion At Patent Expiry
|
|
|
|
